Get startedLog in
    Picture of Alembic Pharmaceuticals logo

    APLLTD — Alembic Pharmaceuticals News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedMid CapHigh Flyer
    All News

    Brief: Alembic Pharmaceuticals Gets USFDA Final Approval For Travoprost Ophthalmic Solution

    Picture of Alembic Pharmaceuticals logoAlembic Pharmaceuticals
    18/12/2025 07:48
    Dec 18 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS:

ALEMBIC PHARMACEUTICALS LTD - USFDA FINAL APPROVAL FOR TRAVOPROST OPHTHALMIC  SOLUTION USP, 0.004%

Source text: ID:nnAZN4RGNCU

Further company coverage: ALEM.NS

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Alembic Pharmaceuticals

    See all news